Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-10-10

Clinical Trial Update: Effects and Safety of Budesonide Inhalation Suspension Via Transnasal Nebulization in Nasal Polyps [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial assessing the safety and effects of budesonide inhalation suspension delivered via transnasal nebulization for nasal polyps has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Budesonide Inhalation Suspension (transnasal nebulization) (budesonide)

Snippet

Sponsor: Beijing Tongren Hospital | Conditions: Nasal Polyps | Phase 2, Phase 3 | Status: COMPLETED